FDA panel recommends clearance of Medtronic’s Amplify spinal implant
By APWednesday, July 28, 2010
FDA panel recommends Medtronic spinal implant
NEW YORK — A Food and Drug Administration advisory panel has recommended clearance for Medtronic’s spinal implant Amplify.
The FDA’s Orthopedic and Rehabilitation Devices Panel voted 6-to-5 in favor of the device, which stimulates bone growth in spinal surgery patients. The FDA normally follows the advice of its panels, though it is not a requirement.
Medtronic makes a range of medical devices, including pacemakers, implantable defibrillators, and spinal implants.
Shares of Medtronic Inc., based in Minneapolis, fell 94 cents, or 2.5 percent, to close Wednesday at $36.45.
(This version CORRECTS first paragraph to change to ’spinal’ implant)
YOUR VIEW POINT
